1 | journal of spine surgery | | | | | | | 10 | 1.43% |
2 | international journal of spine | | | | | | | 9 | 1.28% |
3 | spine surgery june 2024 | | | | | | | 4 | 0.57% |
4 | of spine surgery june | | | | | | | 4 | 0.57% |
5 | anterior cervical discectomy and | | | | | | | 3 | 0.43% |
6 | complications of venous thromboembolism | | | | | | | 2 | 0.29% |
7 | in patients with lumbar | | | | | | | 2 | 0.29% |
8 | bioactive materials in spine | | | | | | | 2 | 0.29% |
9 | and improve pain disability | | | | | | | 2 | 0.29% |
10 | improve pain disability and | | | | | | | 2 | 0.29% |
11 | quality of life in | | | | | | | 2 | 0.29% |
12 | of life in patients | | | | | | | 2 | 0.29% |
13 | life in patients with | | | | | | | 2 | 0.29% |
14 | with lumbar disc degeneration—results | | | | | | | 2 | 0.29% |
15 | patients with lumbar disc | | | | | | | 2 | 0.29% |
16 | volume and improve pain | | | | | | | 2 | 0.29% |
17 | lumbar disc degeneration—results of | | | | | | | 2 | 0.29% |
18 | an fdaapproved biologic therapy | | | | | | | 2 | 0.29% |
19 | fdaapproved biologic therapy randomized | | | | | | | 2 | 0.29% |
20 | evaluation of 3dprinted and | | | | | | | 2 | 0.29% |
21 | of 3dprinted and tps | | | | | | | 2 | 0.29% |
22 | biologic therapy randomized clinical | | | | | | | 2 | 0.29% |
23 | therapy randomized clinical trial | | | | | | | 2 | 0.29% |
24 | materials in spine surgery | | | | | | | 2 | 0.29% |
25 | safely increase disc volume | | | | | | | 2 | 0.29% |
26 | disc volume and improve | | | | | | | 2 | 0.29% |
27 | polyetheretherketone cages vs full | | | | | | | 2 | 0.29% |
28 | fusion a comparative study | | | | | | | 2 | 0.29% |
29 | discectomy and fusion a | | | | | | | 2 | 0.29% |
30 | cervical discectomy and fusion | | | | | | | 2 | 0.29% |
31 | 2level anterior cervical discectomy | | | | | | | 2 | 0.29% |
32 | of venous thromboembolism chemoprophylaxis | | | | | | | 2 | 0.29% |
33 | for standalone 1 or | | | | | | | 2 | 0.29% |
34 | cages for standalone 1 | | | | | | | 2 | 0.29% |
35 | cages vs full titanium | | | | | | | 2 | 0.29% |
36 | technical note on the | | | | | | | 2 | 0.29% |
37 | for this keyword advanced | | | | | | | 2 | 0.29% |
38 | note on the role | | | | | | | 2 | 0.29% |
39 | on the role of | | | | | | | 2 | 0.29% |
40 | kambin’s triangle in the | | | | | | | 2 | 0.29% |